3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Conditions
Keratosis, Actinic
3
Carcinoma, Basal Cell
3
Skin Neoplasms
2
Carcinoma, Squamous Cell
2
Interventions
pembrolizumab
9
Nivolumab
4
Fluorouracil
4
Mohs Surgery
3
talimogene laherparepvec
2
atezolizumab
2
Therapeutics
2
Photochemotherapy
2
Petrolatum
2
Paclitaxel
2
Niacinamide
2
Aminolevulinic Acid
2
tozuleristide
1
smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic
1
selinexor
1
regorafenib
1
peginterferon alfa-2b
1
peginterferon alfa-2a
1
osimertinib
1
nanocis
1
methyl 5-aminolevulinate
1
fludarabine
1
daromun
1
cobimetinib
1
cemiplimab
1
avelumab
1
aldesleukin
1
aflibercept
1
afamelanotide
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Niacinamide
×
Dermatologic
×
Clear all
NCT05955924
2025-02-21
SPRINTR
Women's College Hospital
Phase 3
Recruiting
396 enrolled
NCT03769285
2023-04-06
SPRINTR-Pilot
Women's College Hospital
Phase 2
Unknown
120 enrolled